https://www.selleckchem.com/pr....oducts/ly-3475070.ht
Aim Lynch Syndrome is associated with a significant risk of colorectal carcinoma (CRC) and other cancers. Universal tumor screening is a strategy to identify high-risk individuals by testing all CRC tumors for molecular features suggestive of Lynch Syndrome. Patient interest in screening and preferences for consent have been underexplored. #link# Methods A postal survey was administered to CRC patients in a Canadian province. Results Most patients (81.4%) were willing to have tumors tested if universal tumor screening were available
Like
Comment
Share
